| Financial Year |
March 31 2023 |
| Monetary Funds |
1,260,814,808.44 |
| Held-for-trading Financial Assets |
263,061,508.26 |
| Notes Receivable |
198,234,439.56 |
| Accounts Receivable |
337,694,103.10 |
| Advances to Suppliers |
26,298,474.44 |
| Other Receivables |
16,888,697.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
230,821,957.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
276,290,753.67 |
| Other Current Assets |
5,909,575.41 |
| Total Current Assets |
2,616,014,317.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
263,273,740.91 |
| Investment Properties |
9,111,305.09 |
| Fixed Assetes |
1,247,215,477.31 |
| Under-construction Projects |
52,742,083.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,508,791.71 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,884,678.90 |
| R&D expenses |
-- |
| Goodwill |
27,331,541.79 |
| Long-Term Deferred and Prepaid Expenses |
17,527,664.77 |
| Deferred Income Tax Assets |
22,122,362.44 |
| Other Non-Current Assets |
3,794,052.88 |
| Sub-Total of Non-Current Assets |
1,905,590,086.75 |
| Total Assets |
4,521,604,404.57 |
| Short-Term Loans |
1,779,180.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
67,791,147.93 |
| Accounts Payable |
381,287,123.27 |
| Accounts Received In Advance |
1,573,898.23 |
| Employee Compensation Payable |
59,016,944.66 |
| Taxes Payable |
59,972,881.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
201,449,357.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,381,132.46 |
| Other Current Liabilities |
1,503,124.50 |
| Sub-Total of Current Liabilities |
800,863,438.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
41,942,919.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,521,769.41 |
| Total Liabilities |
845,385,207.46 |
| Paid-In Capital(Or Share Stock) |
511,136,000.00 |
| Capital Surplus |
480,983,653.51 |
| Surplus Reserve |
399,604,682.31 |
| LESS:Treasury Stock |
26,994,240.00 |
| Undistributed Profits |
1,668,859,290.25 |
| Minority Stockholder's Interest |
638,616,466.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,037,602,730.81 |
| Owner's Equity（Stockholder's Equity） |
3,676,219,197.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,521,604,404.57 |
